LI-COR Biotechnology Press Releases

July 16, 2019 – LI-COR Biosciences Introduces DigiWest® to Accelerate Targeted Therapeutics Development

May 15, 2018 – LI-COR Announces New Biotech Distributor for Singapore, Malaysia, Thailand, and Vietnam

April 30, 2018 – LI-COR Announces New Biotech Distributor in Israel

April 13, 2018 – LI-COR Announces New Biotech Distributor in Korea

April 10, 2018 – LI-COR Announces New Biotech Distributor in Japan

July 6, 2017 – LI-COR Introduces Nucleic Acid Gel Analysis With A Safe, Consistent, Single-System Workflow

March 29, 2017 – LI-COR Sponsors Clinical Trial For Near Infrared Surgical Imaging

March 9, 2017 - Growing Concern Over Reliability of Experiments Adds Pressure for Researchers

June 20, 2016 – LI-COR Licenses IRDye technology to QVQ for Pre-Clinical Cancer Research

April 30, 2015 - Aspyrian Therapeutics Inc. Announces FDA Acceptance of an Investigational New Drug Application for RM-1929, a First-in-Class, Precision-Targeted Therapy for Cance

Mar 5, 2015 - Aura Biosciences Closes $21M Series B Financing - Prepares to enter clinical trials for the treatment of rare ocular cancers

Apr 21, 2010 - Study Published on Toxicity of IRDye®® 800CW Carboxylate in Sprague Dawley Rats

Dec 9, 2009 - Spectros and LI-COR Biosciences Enter an Agreement to Develop Real-Time Imaging Agents for Prostate and Ovarian Cancer Surgery.

Oct 21, 2009 - LI-COR Reports on Toxicity Study of its IRDye® 800CW Carboxylate at Global Imaging Summit in Berlin

Sep 10, 2007 - LI-COR Infrared Dye Successfully Completes Toxicity Studies

chat iconChat With Us
chat icon disabled